100 related articles for article (PubMed ID: 32916013)
1. The role of Nodal and Cripto-1 in human oral squamous cell carcinoma.
Daraghma H; Untiveros G; Raskind A; Iaccarino E; Sandomenico A; Ruvo M; Arnouk H; Ciancio MJ; Cuevas-Nunez M; Strizzi L
Oral Dis; 2021 Jul; 27(5):1137-1147. PubMed ID: 32916013
[TBL] [Abstract][Full Text] [Related]
2. The role of Cripto-1 in the tumorigenesis and progression of oral squamous cell carcinoma.
Yoon HJ; Hong JS; Shin WJ; Lee YJ; Hong KO; Lee JI; Hong SP; Hong SD
Oral Oncol; 2011 Nov; 47(11):1023-31. PubMed ID: 21824804
[TBL] [Abstract][Full Text] [Related]
3. Migration and invasion of oral squamous carcinoma cells is promoted by WNT5A, a regulator of cancer progression.
Prgomet Z; Axelsson L; Lindberg P; Andersson T
J Oral Pathol Med; 2015 Nov; 44(10):776-84. PubMed ID: 25459554
[TBL] [Abstract][Full Text] [Related]
4. circ_0005379 inhibits the progression of oral squamous cell carcinoma by regulating the miR-17-5p/acyl-CoA oxidase 1 axis.
Zhou HX; Wang LY; Chen S; Wang DD; Fang Z
Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Aug; 39(4):425-433. PubMed ID: 34409798
[TBL] [Abstract][Full Text] [Related]
5. Sonic Hedgehog Signalling Activation Contributes to ALCAM Over-Expression and Poor Clinical Outcome in Patients with Oral Squamous Cell Carcinoma.
Chen G; Yan M; Li RR; Chen WT
Chin J Dent Res; 2018; 21(1):31-40. PubMed ID: 29507910
[TBL] [Abstract][Full Text] [Related]
6. Letter to editor "The Role of Nodal and Cripto-1 in Human Oral Squamous Cell Carcinoma".
Jain A; Ghoshal S; Pal A
Oral Dis; 2022 Jan; 28(1):245-246. PubMed ID: 33215782
[No Abstract] [Full Text] [Related]
7. New insights into redox-related risk factors and therapeutic targets in oral squamous cell carcinoma.
Dewenter I; Kumbrink J; Poxleitner P; Smolka W; Liokatis P; Fliefel R; Otto S; Obermeier KT
Oral Oncol; 2023 Dec; 147():106573. PubMed ID: 37951115
[TBL] [Abstract][Full Text] [Related]
8. [Effect of circular RNA hsa_circ_0063772 on proliferation, migration and invasion of oral squamous cell carcinoma cells].
Wang F; Wang YF; Su W; Yang HJ; Yang HY
Zhonghua Kou Qiang Yi Xue Za Zhi; 2019 Aug; 54(8):561-567. PubMed ID: 31378036
[No Abstract] [Full Text] [Related]
9. Pituitary tumor-transforming gene 1 (PTTG1) is overexpressed in oral squamous cell carcinoma (OSCC) and promotes migration, invasion and epithelial-mesenchymal transition (EMT) in SCC15 cells.
Zhang E; Liu S; Xu Z; Huang S; Tan X; Sun C; Lu L
Tumour Biol; 2014 Sep; 35(9):8801-11. PubMed ID: 24879625
[TBL] [Abstract][Full Text] [Related]
10. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
11. Expression of ABCG2 and Bmi-1 in oral potentially malignant lesions and oral squamous cell carcinoma.
Dalley AJ; Pitty LP; Major AG; Abdulmajeed AA; Farah CS
Cancer Med; 2014 Apr; 3(2):273-83. PubMed ID: 24415717
[TBL] [Abstract][Full Text] [Related]
12. Growth differentiation factor 15 as a radiation-induced marker in oral carcinoma increasing radiation resistance.
Schiegnitz E; Kämmerer PW; Rode K; Schorn T; Brieger J; Al-Nawas B
J Oral Pathol Med; 2016 Jan; 45(1):63-9. PubMed ID: 25880686
[TBL] [Abstract][Full Text] [Related]
13. Expression of syndecan-1 in oral cavity squamous cell carcinoma.
Woźniak M; Nahajowski M; Hnitecka S; Rutkowska M; Nowak M; Mitelsztet P; Szkudlarek D; Makuch S
J Histotechnol; 2021 Mar; 44(1):46-51. PubMed ID: 33357145
[TBL] [Abstract][Full Text] [Related]
14. Tumour mismatch repair protein loss is associated with advanced stage in oral cavity squamous cell carcinoma.
Vasan K; Satgunaseelan L; Anand S; Asher R; Selinger C; Low TH; Palme CE; Clark JR; Gupta R
Pathology; 2019 Dec; 51(7):688-695. PubMed ID: 31630878
[TBL] [Abstract][Full Text] [Related]
15. Zinc finger AN1-type containing 4 is a novel marker for predicting metastasis and poor prognosis in oral squamous cell carcinoma.
Kurihara-Shimomura M; Sasahira T; Nakamura H; Nakashima C; Kuniyasu H; Kirita T
J Clin Pathol; 2018 May; 71(5):436-441. PubMed ID: 29074611
[TBL] [Abstract][Full Text] [Related]
16. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
Lu M; Wang C; Chen W; Mao C; Wang J
DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
[TBL] [Abstract][Full Text] [Related]
17. Elevated Levels of Urinary PGE-M Are Found in Tobacco Users and Indicate a Poor Prognosis for Oral Squamous Cell Carcinoma Patients.
Kekatpure VD; Bs N; Wang H; Zhou XK; Kandasamy C; Sunny SP; Suresh A; Milne GL; Kuriakose MA; Dannenberg AJ
Cancer Prev Res (Phila); 2016 Jun; 9(6):428-36. PubMed ID: 27045033
[TBL] [Abstract][Full Text] [Related]
18. Bcl-xL expression and regulation in the progression, recurrence, and cisplatin resistance of oral cancer.
Alam M; Mishra R
Life Sci; 2021 Sep; 280():119705. PubMed ID: 34111459
[TBL] [Abstract][Full Text] [Related]
19. MCP-1 as a potential target to inhibit the bone invasion by oral squamous cell carcinoma.
Quan J; Morrison NA; Johnson NW; Gao J
J Cell Biochem; 2014 Oct; 115(10):1787-98. PubMed ID: 24905457
[TBL] [Abstract][Full Text] [Related]
20. Programmed cell death 4 loss increases tumor cell invasion and is regulated by miR-21 in oral squamous cell carcinoma.
Reis PP; Tomenson M; Cervigne NK; Machado J; Jurisica I; Pintilie M; Sukhai MA; Perez-Ordonez B; Grénman R; Gilbert RW; Gullane PJ; Irish JC; Kamel-Reid S
Mol Cancer; 2010 Sep; 9():238. PubMed ID: 20831814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
